In AIDS-Related Lymphoma, Outcomes Worse With Hypoalbuminemia

FRIDAY, June 24, 2022 (HealthDay News) -- For patients with AIDS-related lymphoma (ARL), hypoalbuminemia predicts inferior outcome, according to a study published online June 18 in Infectious Agents and Cancer.
Jinxin Zhang, from Nanfang Hospital in Guangzhou, China, and colleagues retrospectively analyzed de novo ARL patients from 2013 to 2019 to examine factors correlating with progression-free survival (PFS) and overall survival (OS). Eighty-six ARL patients were enrolled and followed for a median of 34 months.
The researchers found that the OS and two-year PFS rates were 37.5 and 35.4 percent, respectively, in the cohort. Inferior survival was predicted by older age and hypoalbuminemia in multivariate models. Worse OS and two-year PFS were seen for ARL patients with hypoalbuminemia, which was associated with poor Eastern Cooperative Oncology Group performance status and a higher International Prognosis Index score.
"We showed that hypoalbuminemia is a simple and effective prognostic factor in AIDS-related lymphoma patients," the authors write. "For ARL patients with hypoalbuminemia, closer follow-up and timely intervention are necessary."
Related Posts
AHA News: A 3-year-old girl with Down syndrome is already a model and ambassador of the heart
THURSDAY, Oct. 7, 2021 (American Heart Association News) -- Heart surgery can be...
Pulse CO Oximeters Not Accurate for Assessing Blood Carboxyhemoglobin
THURSDAY, Oct. 20, 2022 (HealthDay News) -- The use of noninvasive pulse carbon...
U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
THURSDAY, June 30, 2022 (HealthDay News) -- Anticipating a surge in booster...
Olokizumab Tops Placebo for RA Patients Receiving Methotrexate
THURSDAY, Aug. 25, 2022 (HealthDay News) -- Olokizumab is superior to placebo...